BIOGENOMICS

Active

Private limited companyfounded 2025active for 1 yearDiestsesteenweg(LIN) 185, 3210 Lubbeek, BelgiumKBO/BCE: BE 1024.646.137

Summary

BIOGENOMICS has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €19,253 and a net result of €20,086. Its solvency ranks better than 40% of 38,834 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

BIOGENOMICSActiveChecked score 95/100

Risk analysis Report Compare

History

On 24 June 2025, BIOGENOMICS was incorporated as a private limited company.¹ The company has filed annual accounts once, for financial year 2025.²

Acts, filings and financial milestones

All 2Gazette 1Filings 1

2026

29-05

NBB filing Annual accounts filed

financial year 2025 · micro format

2025

26-06

Gazette deed Incorporation

Appointment: MAES Gregory (director) · Founder · Share issue11 facts ▸

Founder, MAES Gregory (comparant)
Incorporation, “Biogenomics” (deed in Dutch)
Share issue, “op naam”, 100 (deed in Dutch)
Other provision, “De inbreng wordt geboekt op een beschikbare eigen vermogensrekening van de vennootschap.” (deed in Dutch)
Capital
Registered office clause, “Linden (B-3210 Lubbeek), Diestsesteenweg 185” (deed in Dutch)
Director appointment, MAES Gregory (director)
Power of attorney, Céline Voet
Power of attorney
Founding capital, €1
Other provision, “End of the statutes excerpt and introduction to the transitional provisions (overgangsbepalingen).” (deed in Dutch)

Gazette deedNBB filing

1 of 1 deed read